Description

Frag 176-191 5mg is supplied as a lyophilized laboratory material in a single-vial presentation for controlled analytical
handling, cataloged storage, and structured research operations. Frag 176-191 is a synthetic peptide fragment
identified in laboratory contexts as a defined sequence segment examined within peptide-focused research and
investigational review environments. Each vial contains 5mg of the identified material and is packaged in Axiom’s
secured, lot-tracked presentation format to support inventory control, traceability, and internal laboratory
recordkeeping. For laboratory research use only. Not for human or veterinary use. Not for diagnosis, treatment, cure,
mitigation, or prevention of disease. Not for clinical use.